Reid M. Huber - Jan 3, 2023 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC (BLCM)

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Stock symbol
BLCM
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/20/2023, 01:24 PM
Date Of Original Report
Jan 5, 2023
Previous filing
Sep 2, 2022
Next filing
Jun 8, 2023
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023.